Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Bristol-Myers Squibb patents novel HIV attachment inhibitors

Jan. 19, 2012

Avixgen patents new candidate drugs for HIV infection

Jan. 19, 2012

Novel agents for HIV infection synthesized in Korea

Jan. 18, 2012

Sumagen set to start phase I testing of new HIV vaccine

Jan. 17, 2012

DFH Pharma and NCI enter collaboration

Jan. 13, 2012

Sangamo BioSciences begins two phase II trials in HIV

Jan. 12, 2012

Clinical study of intranasally administered HIV vaccine fully enrolled

Jan. 10, 2012

Profectus BioSciences begins immunization with HIV vaccine in phase I trial

Jan. 9, 2012

FDA accepts NDA for Quad HIV regimen

Dec. 29, 2011

Researchers begin first clinical study of new HIV vaccine

Dec. 28, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...